行情

AIM

AIM

Aim Immunotech
AMEX
0.3974
+0.0024
+0.61%
盘后: 0.4100 +0.0126 +3.17% 16:39 12/06 EST
开盘
0.3950
昨收
0.3950
最高
0.4100
最低
0.3836
成交量
8.70万
成交额
0
52周最高
1.430
52周最低
0.3705
市值
1,910.79万
市盈率(TTM)
-0.9125
分时
5日
1月
3月
1年
5年
AIM ImmunoTech 表示特拉华州衡平法院拒绝 Activist Group 的董事会提名竞标
AIM ImmunoTech 表示特拉华州衡平法院拒绝 Activist Group 的董事会提名竞标
MT Newswires · 10/31 12:59
AIM ImmunoTech 表示,美国 FDA 批准 IND 申请以评估 Ampligen 在 COVID 后状况的中期研究中
AIM ImmunoTech 表示,美国 FDA 批准 IND 申请以评估 Ampligen 在 COVID 后状况的中期研究中
MT Newswires · 10/12 10:14
AIM ImmunoTech 表示正在进行皮肤癌联合治疗的第 2 期研究;股价上涨前钟
AIM ImmunoTech 表示正在进行皮肤癌联合治疗的第 2 期研究;股价上涨前钟
MT Newswires · 08/30 09:27
AIM 简况
AIM ImmunoTech Inc. is an immuno-pharmaceutical company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases and immune-deficiency disorders. The Company’s flagship products are Ampligen (rintatolimod), a drug of large macromolecular ribonucleic acid (RNA) molecules, and Alferon N Injection (Interferon Alfa-N3). Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS) and is an experimental drug in the United States undergoing clinical development for the treatment of certain cancers and ME/CFS. Alferon N Injection is the registered trademark for its injectable formulation of natural alpha interferon. Alferon N Injection is a natural-source, multi-species alpha interferon approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.

微牛提供AIM ImmunoTech Inc(AMEX-AIM)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的AIM股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易AIM股票基本功能。